Rite Aid reports Q3 SSS down 1.5% Same store sales for the quarter decreased 1.5% over the prior year 13-week period, consisting of a 1.1% increase in front end sales offset by a 2.7% decrease in pharmacy sales. Pharmacy sales included an approximate 924 basis point negative impact from new generic introductions. The number of prescriptions filled in same stores increased 3.6% over the prior year period, which includes the benefit of additional prescriptions resulting from the Walgreens (WAG)-Express Scripts (ESRX) dispute. Prescription sales accounted for 67.8% of total drugstore sales, and third party prescription revenue was 96.5% of pharmacy sales.
Stocks with call strike movement; RAD AAL Rite Aid (RAD) October 10 call option implied volatility decreased 5% to 40, American Airlines (AAL) November 50 call option implied volatility increased 4% to 37 according to IVolatility.